| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans Proteins | 50 | 2022 | 852 | 7.240 |
Why?
|
| Caenorhabditis elegans | 61 | 2022 | 1420 | 6.620 |
Why?
|
| Longevity | 21 | 2022 | 1069 | 3.610 |
Why?
|
| DNA-Binding Proteins | 38 | 2021 | 9647 | 2.260 |
Why?
|
| Transcription Factors | 41 | 2021 | 12207 | 2.140 |
Why?
|
| Germ Cells | 9 | 2015 | 631 | 1.370 |
Why?
|
| Transcription, Genetic | 22 | 2013 | 7723 | 1.230 |
Why?
|
| Unfolded Protein Response | 4 | 2018 | 233 | 1.100 |
Why?
|
| NF-E2-Related Factor 2 | 6 | 2017 | 377 | 1.060 |
Why?
|
| Caloric Restriction | 2 | 2019 | 302 | 0.970 |
Why?
|
| Immediate-Early Proteins | 6 | 2014 | 453 | 0.960 |
Why?
|
| Oxidative Stress | 14 | 2018 | 3085 | 0.950 |
Why?
|
| Helminth Proteins | 7 | 2005 | 171 | 0.930 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2019 | 2108 | 0.890 |
Why?
|
| RNA Nucleotidyltransferases | 5 | 2009 | 64 | 0.880 |
Why?
|
| Pulmonary Fibrosis | 4 | 2018 | 529 | 0.770 |
Why?
|
| Stress, Physiological | 6 | 2016 | 1404 | 0.710 |
Why?
|
| NF-E2-Related Factor 1 | 3 | 2022 | 23 | 0.670 |
Why?
|
| Gene Expression Regulation | 23 | 2017 | 12075 | 0.640 |
Why?
|
| Cysteine | 3 | 2021 | 874 | 0.640 |
Why?
|
| Transcription Factor TFIID | 3 | 2004 | 151 | 0.630 |
Why?
|
| Signal Transduction | 24 | 2022 | 23404 | 0.610 |
Why?
|
| Pulmonary Alveoli | 3 | 2018 | 675 | 0.590 |
Why?
|
| Animals | 110 | 2022 | 168788 | 0.570 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2019 | 2014 | 0.570 |
Why?
|
| Aging | 8 | 2019 | 8661 | 0.550 |
Why?
|
| RNA Interference | 13 | 2016 | 2890 | 0.550 |
Why?
|
| Immunity, Innate | 5 | 2021 | 2958 | 0.530 |
Why?
|
| Endoribonucleases | 2 | 2018 | 231 | 0.530 |
Why?
|
| TATA-Binding Protein Associated Factors | 3 | 2004 | 104 | 0.450 |
Why?
|
| Oogenesis | 3 | 2008 | 131 | 0.450 |
Why?
|
| RNA, Helminth | 3 | 2009 | 59 | 0.420 |
Why?
|
| Oocytes | 3 | 2006 | 1187 | 0.420 |
Why?
|
| Embryo, Nonmammalian | 6 | 2013 | 894 | 0.420 |
Why?
|
| Sirtuins | 1 | 2014 | 323 | 0.400 |
Why?
|
| Antioxidants | 4 | 2021 | 1663 | 0.400 |
Why?
|
| Endoplasmic Reticulum | 4 | 2018 | 1144 | 0.400 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2011 | 33 | 0.400 |
Why?
|
| Macrophages, Alveolar | 3 | 2014 | 407 | 0.390 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 6 | 2021 | 697 | 0.390 |
Why?
|
| Gene Silencing | 3 | 2008 | 1538 | 0.390 |
Why?
|
| Forkhead Transcription Factors | 6 | 2019 | 1613 | 0.380 |
Why?
|
| Multiprotein Complexes | 2 | 2014 | 1119 | 0.380 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2022 | 1337 | 0.380 |
Why?
|
| NAD | 1 | 2014 | 594 | 0.380 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2014 | 3617 | 0.370 |
Why?
|
| DNA | 13 | 2003 | 7303 | 0.370 |
Why?
|
| Apoptosis | 7 | 2018 | 9728 | 0.350 |
Why?
|
| Sirolimus | 2 | 2019 | 1563 | 0.350 |
Why?
|
| Molecular Sequence Data | 30 | 2005 | 18116 | 0.350 |
Why?
|
| Metformin | 1 | 2016 | 835 | 0.350 |
Why?
|
| RNA-Binding Proteins | 4 | 2005 | 1903 | 0.340 |
Why?
|
| RNA, Messenger, Stored | 1 | 2008 | 6 | 0.340 |
Why?
|
| Polysomnography | 7 | 2016 | 1775 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2014 | 987 | 0.330 |
Why?
|
| Cytoplasm | 3 | 2016 | 1539 | 0.330 |
Why?
|
| Cytoplasmic Structures | 1 | 2008 | 21 | 0.330 |
Why?
|
| Insulin | 5 | 2019 | 6583 | 0.330 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2008 | 30 | 0.320 |
Why?
|
| Endoderm | 2 | 2013 | 154 | 0.320 |
Why?
|
| RNA Polymerase II | 6 | 2006 | 551 | 0.310 |
Why?
|
| Phosphorylation | 12 | 2014 | 8437 | 0.310 |
Why?
|
| Lipid Metabolism | 2 | 2015 | 1888 | 0.300 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2004 | 1888 | 0.300 |
Why?
|
| Meiosis | 2 | 2008 | 339 | 0.290 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2019 | 430 | 0.290 |
Why?
|
| Collagen | 2 | 2014 | 2689 | 0.280 |
Why?
|
| Cytoplasmic Granules | 3 | 2009 | 610 | 0.280 |
Why?
|
| Mitochondria | 7 | 2021 | 3520 | 0.280 |
Why?
|
| Amino Acid Sequence | 18 | 2013 | 13817 | 0.280 |
Why?
|
| Herpesviridae Infections | 1 | 2008 | 277 | 0.280 |
Why?
|
| Immunoglobulin Variable Region | 10 | 1991 | 421 | 0.270 |
Why?
|
| Mesoderm | 2 | 2013 | 686 | 0.270 |
Why?
|
| Ubiquitin | 1 | 2011 | 852 | 0.270 |
Why?
|
| MyoD Protein | 6 | 2000 | 151 | 0.270 |
Why?
|
| Lipopolysaccharides | 6 | 2017 | 2216 | 0.270 |
Why?
|
| Protein Biosynthesis | 2 | 2010 | 2126 | 0.270 |
Why?
|
| Conserved Sequence | 3 | 2006 | 1202 | 0.260 |
Why?
|
| Muscle Strength | 1 | 2009 | 592 | 0.260 |
Why?
|
| I-kappa B Kinase | 3 | 2014 | 252 | 0.250 |
Why?
|
| Osteoporosis | 5 | 2010 | 1580 | 0.250 |
Why?
|
| Clodronic Acid | 1 | 2004 | 60 | 0.250 |
Why?
|
| Drosophila Proteins | 4 | 2019 | 1702 | 0.250 |
Why?
|
| Movement | 2 | 2015 | 1471 | 0.240 |
Why?
|
| Leucine Zippers | 3 | 2000 | 117 | 0.240 |
Why?
|
| NF-kappa B | 4 | 2013 | 2501 | 0.240 |
Why?
|
| Zinc Fingers | 3 | 2002 | 585 | 0.230 |
Why?
|
| Binding Sites | 16 | 2013 | 6116 | 0.230 |
Why?
|
| Nuclear Proteins | 6 | 2008 | 5853 | 0.230 |
Why?
|
| Salix | 1 | 2012 | 3 | 0.230 |
Why?
|
| Geriatric Assessment | 3 | 2009 | 1372 | 0.230 |
Why?
|
| Cognition Disorders | 6 | 2009 | 4041 | 0.220 |
Why?
|
| Electrophysiology | 1 | 2005 | 1310 | 0.210 |
Why?
|
| Aspartic Acid Proteases | 1 | 2022 | 9 | 0.210 |
Why?
|
| Repressor Proteins | 4 | 2012 | 3023 | 0.200 |
Why?
|
| Transcriptional Activation | 3 | 2006 | 1782 | 0.200 |
Why?
|
| Transcription Factors, TFII | 1 | 2001 | 60 | 0.200 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2022 | 81 | 0.200 |
Why?
|
| Nocturnal Myoclonus Syndrome | 2 | 2015 | 50 | 0.200 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2021 | 57 | 0.200 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2002 | 166 | 0.200 |
Why?
|
| Base Sequence | 22 | 2013 | 12801 | 0.190 |
Why?
|
| Genes, Immunoglobulin | 7 | 1994 | 291 | 0.190 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 375 | 0.190 |
Why?
|
| Transfection | 7 | 2016 | 5892 | 0.190 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2002 | 211 | 0.190 |
Why?
|
| Hydrogen Sulfide | 1 | 2022 | 137 | 0.190 |
Why?
|
| RNA Helicases | 1 | 2001 | 142 | 0.190 |
Why?
|
| Cell Nucleus | 6 | 2017 | 2969 | 0.190 |
Why?
|
| Reactive Oxygen Species | 5 | 2017 | 2078 | 0.190 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2016 | 443 | 0.180 |
Why?
|
| Plant Extracts | 2 | 2012 | 472 | 0.180 |
Why?
|
| MicroRNAs | 5 | 2016 | 3747 | 0.180 |
Why?
|
| Tristetraprolin | 5 | 2004 | 42 | 0.180 |
Why?
|
| Fractures, Bone | 3 | 2007 | 1947 | 0.180 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2003 | 671 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2002 | 4419 | 0.170 |
Why?
|
| Receptor, Insulin | 2 | 2017 | 846 | 0.170 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 2 | 1989 | 18 | 0.170 |
Why?
|
| Activating Transcription Factors | 1 | 2019 | 29 | 0.170 |
Why?
|
| Models, Biological | 9 | 2021 | 9582 | 0.170 |
Why?
|
| Drosophila | 3 | 2019 | 1491 | 0.170 |
Why?
|
| Transcription Factor CHOP | 1 | 2018 | 73 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2004 | 3772 | 0.160 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 736 | 0.160 |
Why?
|
| Cell Survival | 4 | 2008 | 5881 | 0.160 |
Why?
|
| Mice | 39 | 2018 | 81178 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 2009 | 5021 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4752 | 0.160 |
Why?
|
| Fungal Proteins | 1 | 2002 | 912 | 0.160 |
Why?
|
| Models, Molecular | 3 | 2003 | 5458 | 0.150 |
Why?
|
| Leg | 2 | 2015 | 1117 | 0.150 |
Why?
|
| Nonheme Iron Proteins | 1 | 2017 | 9 | 0.150 |
Why?
|
| Triclosan | 1 | 2017 | 55 | 0.150 |
Why?
|
| Immunologic Deficiency Syndromes | 4 | 1990 | 547 | 0.150 |
Why?
|
| Pyrimidinones | 1 | 2019 | 371 | 0.150 |
Why?
|
| RNA | 5 | 2004 | 2749 | 0.150 |
Why?
|
| Inflammation | 5 | 2014 | 10634 | 0.140 |
Why?
|
| Homeodomain Proteins | 3 | 2015 | 2422 | 0.140 |
Why?
|
| Lithium | 1 | 2019 | 601 | 0.140 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2015 | 10 | 0.140 |
Why?
|
| Lipogenesis | 1 | 2017 | 212 | 0.140 |
Why?
|
| Receptors, CCR2 | 1 | 2017 | 212 | 0.140 |
Why?
|
| Protein Subunits | 3 | 2004 | 960 | 0.130 |
Why?
|
| Recombination, Genetic | 6 | 1989 | 1586 | 0.130 |
Why?
|
| Hep G2 Cells | 1 | 2016 | 392 | 0.130 |
Why?
|
| Protein Binding | 8 | 2013 | 9392 | 0.130 |
Why?
|
| Pneumonia | 3 | 2017 | 2134 | 0.130 |
Why?
|
| Pyridones | 1 | 2019 | 712 | 0.120 |
Why?
|
| Cell Polarity | 1 | 2018 | 645 | 0.120 |
Why?
|
| Oxidoreductases | 1 | 2017 | 424 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 436 | 0.120 |
Why?
|
| Sleep Deprivation | 2 | 2014 | 832 | 0.120 |
Why?
|
| Nucleic Acid Conformation | 4 | 2000 | 914 | 0.120 |
Why?
|
| RNA Stability | 2 | 2008 | 322 | 0.120 |
Why?
|
| 14-3-3 Proteins | 3 | 2006 | 214 | 0.120 |
Why?
|
| B-Lymphocytes | 13 | 1994 | 4665 | 0.120 |
Why?
|
| Humans | 58 | 2022 | 744220 | 0.120 |
Why?
|
| Muscle Proteins | 4 | 1993 | 1159 | 0.120 |
Why?
|
| Animals, Genetically Modified | 4 | 2022 | 1549 | 0.120 |
Why?
|
| Lung | 5 | 2013 | 9852 | 0.120 |
Why?
|
| DNA Primers | 4 | 2014 | 2892 | 0.120 |
Why?
|
| Sp3 Transcription Factor | 1 | 2013 | 29 | 0.120 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2013 | 31 | 0.110 |
Why?
|
| Liver Transplantation | 1 | 2004 | 2118 | 0.110 |
Why?
|
| Prostaglandin D2 | 1 | 2013 | 122 | 0.110 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 109 | 0.110 |
Why?
|
| Mutation | 11 | 2021 | 29784 | 0.110 |
Why?
|
| Macrophages, Peritoneal | 1 | 2014 | 251 | 0.110 |
Why?
|
| Protein Folding | 3 | 2008 | 843 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 713 | 0.110 |
Why?
|
| Larva | 1 | 2014 | 519 | 0.110 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2007 | 386 | 0.110 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 451 | 0.110 |
Why?
|
| Ubiquitination | 1 | 2017 | 1011 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 4 | 2004 | 2700 | 0.110 |
Why?
|
| Hot Flashes | 2 | 2007 | 317 | 0.110 |
Why?
|
| Lipocalins | 1 | 2013 | 170 | 0.110 |
Why?
|
| Structure-Activity Relationship | 4 | 2002 | 3133 | 0.110 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 1990 | 92 | 0.110 |
Why?
|
| Restless Legs Syndrome | 1 | 2015 | 228 | 0.110 |
Why?
|
| Eating | 1 | 2019 | 1538 | 0.100 |
Why?
|
| Immunoblotting | 2 | 2006 | 1682 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2007 | 375 | 0.100 |
Why?
|
| Sarcoma, Synovial | 1 | 2013 | 167 | 0.100 |
Why?
|
| Trans-Activators | 4 | 2012 | 2924 | 0.100 |
Why?
|
| Lung Injury | 2 | 2007 | 436 | 0.100 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 275 | 0.100 |
Why?
|
| Arsenites | 2 | 2009 | 66 | 0.100 |
Why?
|
| Response Elements | 1 | 2013 | 311 | 0.100 |
Why?
|
| Sleep | 4 | 2015 | 4623 | 0.100 |
Why?
|
| Tunica Intima | 1 | 2013 | 464 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 1213 | 0.100 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 390 | 0.100 |
Why?
|
| Mice, Transgenic | 8 | 2014 | 9735 | 0.100 |
Why?
|
| Immunoglobulin J-Chains | 2 | 1990 | 27 | 0.090 |
Why?
|
| Genes, Regulator | 3 | 2004 | 378 | 0.090 |
Why?
|
| 3T3 Cells | 3 | 2002 | 1101 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 5 | 1995 | 6172 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 5 | 2006 | 3846 | 0.090 |
Why?
|
| Cells, Cultured | 8 | 2018 | 19227 | 0.090 |
Why?
|
| Ribonuclease III | 1 | 2012 | 275 | 0.090 |
Why?
|
| Macromolecular Substances | 6 | 2004 | 1456 | 0.090 |
Why?
|
| RNA, Messenger | 6 | 2012 | 13036 | 0.090 |
Why?
|
| Liver | 3 | 2009 | 7472 | 0.090 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2016 | 943 | 0.090 |
Why?
|
| Models, Genetic | 5 | 2004 | 3494 | 0.090 |
Why?
|
| Mice, Mutant Strains | 4 | 1990 | 1866 | 0.090 |
Why?
|
| Activity Cycles | 1 | 2010 | 51 | 0.090 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2009 | 10 | 0.090 |
Why?
|
| Genes, Reporter | 3 | 2004 | 1547 | 0.090 |
Why?
|
| DNA, Helminth | 1 | 2009 | 34 | 0.090 |
Why?
|
| Sequence Alignment | 4 | 2004 | 2256 | 0.090 |
Why?
|
| Fractures, Spontaneous | 2 | 2010 | 230 | 0.090 |
Why?
|
| Immunoglobulin Heavy Chains | 8 | 1990 | 659 | 0.090 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 3 | 1994 | 154 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4553 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2015 | 1812 | 0.080 |
Why?
|
| Peroxiredoxins | 1 | 2008 | 51 | 0.080 |
Why?
|
| RNA Transport | 1 | 2008 | 48 | 0.080 |
Why?
|
| alpha-Mannosidase | 1 | 2008 | 20 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 2088 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2003 | 1724 | 0.080 |
Why?
|
| RNA Caps | 1 | 2008 | 74 | 0.080 |
Why?
|
| DNA Nucleotidyltransferases | 5 | 1989 | 193 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2021 | 1284 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 1990 | 0.080 |
Why?
|
| Zygote | 1 | 2008 | 116 | 0.080 |
Why?
|
| Intestines | 3 | 2008 | 1924 | 0.080 |
Why?
|
| Imidazoles | 2 | 2012 | 1206 | 0.080 |
Why?
|
| Vasculitis | 1 | 2012 | 521 | 0.080 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2007 | 47 | 0.080 |
Why?
|
| Heat-Shock Response | 1 | 2008 | 165 | 0.080 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2007 | 76 | 0.080 |
Why?
|
| Oxidation-Reduction | 4 | 2021 | 2187 | 0.080 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2006 | 24 | 0.070 |
Why?
|
| Endothelial Cells | 3 | 2012 | 3478 | 0.070 |
Why?
|
| Bleomycin | 3 | 2018 | 501 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1741 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 5 | 2013 | 5867 | 0.070 |
Why?
|
| Aged, 80 and over | 11 | 2016 | 57768 | 0.070 |
Why?
|
| Vitamin E | 1 | 2011 | 869 | 0.070 |
Why?
|
| Cell Differentiation | 7 | 2014 | 11478 | 0.070 |
Why?
|
| Aged | 19 | 2019 | 163253 | 0.070 |
Why?
|
| Genes | 3 | 1986 | 1893 | 0.070 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2005 | 5 | 0.070 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2012 | 835 | 0.070 |
Why?
|
| Proteins | 3 | 2000 | 6101 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2008 | 3036 | 0.070 |
Why?
|
| Positive Transcriptional Elongation Factor B | 2 | 2003 | 43 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 7 | 2017 | 21824 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2003 | 66 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2004 | 2839 | 0.070 |
Why?
|
| Aorta | 1 | 2013 | 2061 | 0.070 |
Why?
|
| Mediator Complex | 2 | 2004 | 109 | 0.070 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 1016 | 0.070 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2013 | 1581 | 0.060 |
Why?
|
| Adipose Tissue | 3 | 2012 | 3278 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 2014 | 3701 | 0.060 |
Why?
|
| HeLa Cells | 3 | 2003 | 3129 | 0.060 |
Why?
|
| Asthma | 2 | 2016 | 6011 | 0.060 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 642 | 0.060 |
Why?
|
| Sleep Stages | 1 | 2009 | 686 | 0.060 |
Why?
|
| Female | 26 | 2019 | 380197 | 0.060 |
Why?
|
| Estrogen Antagonists | 1 | 2005 | 151 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 4 | 1991 | 277 | 0.060 |
Why?
|
| Radiation Chimera | 1 | 2004 | 223 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2005 | 129 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 3047 | 0.060 |
Why?
|
| Immunoglobulin D | 1 | 1984 | 56 | 0.060 |
Why?
|
| TATA Box Binding Protein-Like Proteins | 1 | 2004 | 8 | 0.060 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2004 | 139 | 0.060 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2004 | 32 | 0.060 |
Why?
|
| Health Surveys | 3 | 2016 | 4037 | 0.060 |
Why?
|
| Protein Structure, Secondary | 3 | 1997 | 1246 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2006 | 290 | 0.060 |
Why?
|
| Trifolium | 1 | 2003 | 4 | 0.060 |
Why?
|
| Plasmids | 3 | 2003 | 2307 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 822 | 0.060 |
Why?
|
| Observation | 1 | 2005 | 312 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 5180 | 0.060 |
Why?
|
| Allergens | 1 | 2011 | 1320 | 0.060 |
Why?
|
| Antigens, Viral | 1 | 2008 | 1035 | 0.060 |
Why?
|
| Lymphocytes | 2 | 1989 | 2617 | 0.060 |
Why?
|
| Paraquat | 1 | 2003 | 34 | 0.060 |
Why?
|
| DNA, Recombinant | 1 | 1984 | 476 | 0.060 |
Why?
|
| Histone Chaperones | 1 | 2004 | 76 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 11368 | 0.060 |
Why?
|
| Rest | 1 | 2008 | 901 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 3505 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 2848 | 0.060 |
Why?
|
| Observer Variation | 1 | 2009 | 2593 | 0.060 |
Why?
|
| Immunoglobulin kappa-Chains | 3 | 1994 | 173 | 0.060 |
Why?
|
| Plant Bark | 1 | 2012 | 9 | 0.060 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2012 | 25 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2004 | 2752 | 0.060 |
Why?
|
| Chromatin | 2 | 2006 | 2934 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 742 | 0.060 |
Why?
|
| Gene Rearrangement | 1 | 1989 | 1179 | 0.060 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2003 | 54 | 0.060 |
Why?
|
| Benzyl Alcohols | 1 | 2012 | 29 | 0.060 |
Why?
|
| Bone Density | 2 | 2007 | 3468 | 0.060 |
Why?
|
| Mammals | 1 | 1989 | 1144 | 0.060 |
Why?
|
| Phylogeny | 3 | 2007 | 2803 | 0.060 |
Why?
|
| Postmenopause | 3 | 2007 | 2461 | 0.060 |
Why?
|
| Range of Motion, Articular | 1 | 2009 | 1579 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3703 | 0.050 |
Why?
|
| Ribonucleoproteins | 1 | 2005 | 381 | 0.050 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2012 | 98 | 0.050 |
Why?
|
| Neurons | 2 | 2021 | 9335 | 0.050 |
Why?
|
| DNA, Complementary | 3 | 2003 | 2050 | 0.050 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 2000 | 96 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2013 | 4385 | 0.050 |
Why?
|
| Isoflavones | 1 | 2003 | 139 | 0.050 |
Why?
|
| Embryonic Induction | 1 | 2002 | 149 | 0.050 |
Why?
|
| Hydrogen Peroxide | 2 | 2021 | 731 | 0.050 |
Why?
|
| Male | 19 | 2018 | 350027 | 0.050 |
Why?
|
| Cell Transformation, Viral | 5 | 1990 | 565 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2004 | 1104 | 0.050 |
Why?
|
| Muscles | 2 | 2021 | 1622 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2009 | 3001 | 0.050 |
Why?
|
| Gametogenesis | 1 | 2001 | 26 | 0.050 |
Why?
|
| Time Factors | 3 | 2016 | 40063 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 1537 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13280 | 0.050 |
Why?
|
| Liposomes | 1 | 2004 | 758 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2005 | 1525 | 0.050 |
Why?
|
| Fertility | 2 | 2007 | 780 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2003 | 220 | 0.050 |
Why?
|
| DNA Polymerase II | 1 | 2001 | 107 | 0.050 |
Why?
|
| Cell Line | 7 | 2013 | 15999 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 853 | 0.050 |
Why?
|
| Mice, Knockout | 5 | 2018 | 14556 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2012 | 371 | 0.050 |
Why?
|
| Obesity | 3 | 2014 | 12742 | 0.050 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2021 | 148 | 0.050 |
Why?
|
| Knee Joint | 1 | 2009 | 1680 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 936 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 438 | 0.050 |
Why?
|
| Disorders of Sex Development | 1 | 2001 | 122 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6274 | 0.050 |
Why?
|
| Templates, Genetic | 2 | 1990 | 211 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3921 | 0.050 |
Why?
|
| Accidental Falls | 1 | 2008 | 1062 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 381 | 0.050 |
Why?
|
| Glutathione | 1 | 2012 | 588 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2008 | 2263 | 0.040 |
Why?
|
| Transgenes | 1 | 2003 | 1009 | 0.040 |
Why?
|
| Cross-Sectional Studies | 6 | 2016 | 25043 | 0.040 |
Why?
|
| Body Composition | 1 | 2009 | 2400 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 19907 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2008 | 6991 | 0.040 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2008 | 1004 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 1708 | 0.040 |
Why?
|
| Thymine | 1 | 1999 | 68 | 0.040 |
Why?
|
| Hip Fractures | 1 | 2007 | 955 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2017 | 3689 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2008 | 2420 | 0.040 |
Why?
|
| Glucosides | 1 | 2012 | 451 | 0.040 |
Why?
|
| Abelson murine leukemia virus | 5 | 1990 | 43 | 0.040 |
Why?
|
| Phenotype | 4 | 2004 | 16365 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 4465 | 0.040 |
Why?
|
| Glutathione Transferase | 2 | 1990 | 595 | 0.040 |
Why?
|
| DNA Damage | 1 | 2008 | 2432 | 0.040 |
Why?
|
| VDJ Recombinases | 5 | 1989 | 84 | 0.040 |
Why?
|
| Mortality | 1 | 2010 | 2864 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2009 | 2895 | 0.040 |
Why?
|
| Motor Activity | 1 | 2008 | 2714 | 0.040 |
Why?
|
| DNA Probes | 1 | 1999 | 560 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2002 | 1791 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 2948 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2018 | 150 | 0.040 |
Why?
|
| Vertebrates | 1 | 1999 | 227 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2014 | 12718 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2017 | 104 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 2003 | 1159 | 0.040 |
Why?
|
| Oligonucleotides | 2 | 1990 | 572 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2013 | 3444 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1731 | 0.040 |
Why?
|
| Tissue Distribution | 3 | 2008 | 2335 | 0.040 |
Why?
|
| Mental Status Schedule | 2 | 2008 | 321 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2007 | 4156 | 0.040 |
Why?
|
| Xenopus | 1 | 1999 | 712 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2004 | 1548 | 0.040 |
Why?
|
| Alleles | 4 | 2015 | 6938 | 0.040 |
Why?
|
| Kinetics | 1 | 2004 | 6474 | 0.040 |
Why?
|
| Garlic | 1 | 2016 | 29 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1660 | 0.030 |
Why?
|
| Diet | 1 | 2014 | 7937 | 0.030 |
Why?
|
| Feedback | 1 | 2000 | 795 | 0.030 |
Why?
|
| Xenopus Proteins | 1 | 1999 | 433 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2006 | 2050 | 0.030 |
Why?
|
| Open Reading Frames | 2 | 2014 | 810 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 15525 | 0.030 |
Why?
|
| Cloning, Molecular | 5 | 2003 | 4321 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 675 | 0.030 |
Why?
|
| Rabbits | 1 | 2002 | 4892 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2005 | 1343 | 0.030 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1995 | 19 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2001 | 1701 | 0.030 |
Why?
|
| G-Box Binding Factors | 1 | 1994 | 9 | 0.030 |
Why?
|
| Menopause | 1 | 2003 | 1626 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1995 | 104 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2014 | 2726 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1995 | 240 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2003 | 2504 | 0.030 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1994 | 63 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1526 | 0.030 |
Why?
|
| Endocrine Disruptors | 1 | 2017 | 237 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2019 | 1962 | 0.030 |
Why?
|
| Pyrvinium Compounds | 1 | 2013 | 4 | 0.030 |
Why?
|
| Oncogenes | 1 | 2000 | 1265 | 0.030 |
Why?
|
| Autoradiography | 1 | 1995 | 749 | 0.030 |
Why?
|
| Risk Factors | 6 | 2015 | 72280 | 0.030 |
Why?
|
| Adenine | 1 | 1999 | 936 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 2013 | 128 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 2085 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2015 | 40559 | 0.030 |
Why?
|
| Spirometry | 1 | 2016 | 864 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2013 | 242 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 2008 | 0.030 |
Why?
|
| Karyopherins | 1 | 2013 | 137 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2021 | 1881 | 0.030 |
Why?
|
| alpha Karyopherins | 1 | 2012 | 41 | 0.030 |
Why?
|
| Protein Conformation | 2 | 1990 | 4012 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 996 | 0.030 |
Why?
|
| Immunoglobulins | 2 | 1986 | 881 | 0.030 |
Why?
|
| Starvation | 1 | 2012 | 134 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.030 |
Why?
|
| Gravitation | 1 | 2012 | 82 | 0.030 |
Why?
|
| Macrophages | 3 | 2013 | 5657 | 0.030 |
Why?
|
| Chemokine CCL20 | 1 | 2012 | 64 | 0.030 |
Why?
|
| Leukocytes | 2 | 2012 | 2040 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 3800 | 0.030 |
Why?
|
| Genes, myc | 1 | 1993 | 399 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2014 | 5180 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 905 | 0.020 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 1990 | 24 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2014 | 558 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2003 | 6612 | 0.020 |
Why?
|
| Pyridines | 1 | 2012 | 2822 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 611 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2014 | 766 | 0.020 |
Why?
|
| Dementia | 1 | 2005 | 2518 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1993 | 315 | 0.020 |
Why?
|
| Endotoxemia | 1 | 2012 | 206 | 0.020 |
Why?
|
| Disulfides | 1 | 1992 | 457 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2003 | 3297 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2012 | 431 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 1990 | 140 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2016 | 9849 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 809 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 1407 | 0.020 |
Why?
|
| Neuroimmunomodulation | 1 | 2012 | 157 | 0.020 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1990 | 97 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5096 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 567 | 0.020 |
Why?
|
| E-Selectin | 1 | 2012 | 579 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 5529 | 0.020 |
Why?
|
| Prevalence | 3 | 2016 | 15226 | 0.020 |
Why?
|
| Serine | 2 | 2004 | 828 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2017 | 1808 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 707 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10949 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 1997 | 3760 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2014 | 1880 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1993 | 794 | 0.020 |
Why?
|
| Cricetinae | 1 | 2013 | 2472 | 0.020 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2009 | 55 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 18027 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1990 | 2540 | 0.020 |
Why?
|
| Antibodies | 2 | 1987 | 2461 | 0.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1989 | 111 | 0.020 |
Why?
|
| Severity of Illness Index | 4 | 2007 | 15538 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1990 | 799 | 0.020 |
Why?
|
| Cholesterol | 1 | 2017 | 2911 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 3 | 1996 | 1341 | 0.020 |
Why?
|
| Spinal Fractures | 2 | 2005 | 696 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2015 | 3588 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 380 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4201 | 0.020 |
Why?
|
| Antibody Diversity | 1 | 1987 | 74 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1438 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2903 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2009 | 517 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3637 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 21672 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 39045 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 2025 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1984 | 570 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2007 | 203 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 1869 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5974 | 0.020 |
Why?
|
| Electrooculography | 1 | 2006 | 118 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1628 | 0.020 |
Why?
|
| United States | 5 | 2016 | 69867 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2014 | 1782 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4803 | 0.020 |
Why?
|
| Peptides | 2 | 2003 | 4407 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2012 | 1076 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2007 | 262 | 0.020 |
Why?
|
| Actigraphy | 1 | 2010 | 488 | 0.020 |
Why?
|
| Snoring | 1 | 2007 | 191 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 261 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2009 | 595 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2009 | 1005 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 767 | 0.020 |
Why?
|
| Fetus | 1 | 2013 | 1880 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3557 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2007 | 331 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6367 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 1677 | 0.020 |
Why?
|
| Immunoglobulin Fragments | 1 | 1984 | 84 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 4188 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1989 | 1401 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2014 | 1885 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1984 | 322 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 1984 | 290 | 0.010 |
Why?
|
| Uridine | 1 | 2004 | 146 | 0.010 |
Why?
|
| Rats | 2 | 2006 | 24273 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2012 | 1809 | 0.010 |
Why?
|
| Fatty Liver | 1 | 2009 | 729 | 0.010 |
Why?
|
| Phytoestrogens | 1 | 2003 | 61 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2886 | 0.010 |
Why?
|
| California | 1 | 2007 | 1402 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 1725 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 29142 | 0.010 |
Why?
|
| Plant Preparations | 1 | 2003 | 94 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 255 | 0.010 |
Why?
|
| Adipocytes | 1 | 2009 | 1182 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2007 | 2007 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2003 | 287 | 0.010 |
Why?
|
| Comorbidity | 2 | 2008 | 10387 | 0.010 |
Why?
|
| Histidine | 1 | 2003 | 313 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2003 | 562 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2014 | 53280 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 2624 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3201 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2009 | 13990 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13409 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 1161 | 0.010 |
Why?
|
| Neutrophils | 1 | 2013 | 3717 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2003 | 475 | 0.010 |
Why?
|
| Mental Recall | 1 | 2007 | 1205 | 0.010 |
Why?
|
| Alanine | 1 | 2003 | 572 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 1708 | 0.010 |
Why?
|
| Placebos | 1 | 2005 | 1677 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 1434 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1458 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1984 | 802 | 0.010 |
Why?
|
| Cell Movement | 1 | 2012 | 5216 | 0.010 |
Why?
|
| Cause of Death | 1 | 2010 | 3584 | 0.010 |
Why?
|
| Critical Illness | 1 | 2012 | 2670 | 0.010 |
Why?
|
| Middle Aged | 5 | 2019 | 213367 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6535 | 0.010 |
Why?
|
| Psychometrics | 1 | 2008 | 3002 | 0.010 |
Why?
|
| Adenosine | 1 | 2004 | 825 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 2557 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 6461 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 21752 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2003 | 1169 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 1939 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 8426 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1984 | 2942 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 1581 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 3079 | 0.010 |
Why?
|
| T-Lymphocytes | 4 | 1990 | 10182 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 16687 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 4935 | 0.010 |
Why?
|
| Genes, MHC Class II | 2 | 1989 | 457 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 1076 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2009 | 3863 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1996 | 573 | 0.010 |
Why?
|
| Hypertension | 1 | 2015 | 8480 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 1950 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2005 | 6037 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 9685 | 0.010 |
Why?
|
| Ovary | 1 | 1999 | 981 | 0.010 |
Why?
|
| Interleukin-7 | 1 | 1994 | 142 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1996 | 655 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2916 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9147 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1994 | 898 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 1992 | 182 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1992 | 354 | 0.010 |
Why?
|
| Adult | 3 | 2013 | 214035 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1996 | 1801 | 0.010 |
Why?
|
| Mice, Inbred NZB | 1 | 1991 | 56 | 0.010 |
Why?
|
| Vitamin D | 1 | 2005 | 3222 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2006 | 6150 | 0.010 |
Why?
|
| Immunoglobulin delta-Chains | 1 | 1990 | 7 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 18367 | 0.010 |
Why?
|
| Hybridomas | 1 | 1991 | 452 | 0.010 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1990 | 59 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2440 | 0.010 |
Why?
|
| Genetic Engineering | 2 | 1986 | 952 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1990 | 878 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 12035 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1989 | 113 | 0.010 |
Why?
|
| Gene Expression | 2 | 1994 | 7799 | 0.010 |
Why?
|
| Multigene Family | 1 | 1991 | 1102 | 0.000 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 3461 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 56436 | 0.000 |
Why?
|
| Depression | 1 | 2006 | 7767 | 0.000 |
Why?
|
| Incidence | 1 | 2005 | 20945 | 0.000 |
Why?
|
| Bone Marrow Cells | 1 | 1994 | 2513 | 0.000 |
Why?
|
| Genetic Code | 1 | 1986 | 154 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 85759 | 0.000 |
Why?
|
| Deoxyribonucleases | 1 | 1986 | 214 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 8037 | 0.000 |
Why?
|
| Plasmacytoma | 1 | 1984 | 183 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2005 | 23337 | 0.000 |
Why?
|
| Immune System Diseases | 1 | 1986 | 263 | 0.000 |
Why?
|
| Kidney | 1 | 1999 | 7183 | 0.000 |
Why?
|
| Quality of Life | 1 | 2003 | 12805 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1992 | 4220 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 77426 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2005 | 63119 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1990 | 3385 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1986 | 4742 | 0.000 |
Why?
|
| Lymphoma | 1 | 1984 | 1873 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1984 | 2944 | 0.000 |
Why?
|